Ventas Inc(VTR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 165.88 | EPS (ttm) | 0.55 | Insider Own | 0.57% | Shs Outstand | 513.0M | Perf Week | -1.76% |
| Market Cap | 47.42B | Forward P/E | 96.04 | EPS next Y | 61.57% | Insider Trans | 0.05% | Shs Float | 510.0M | Perf Month | 4% |
| Enterprise Value | 60.74B | PEG | 2.92 | EPS next Q | 0.16 | Inst Own | 104.66% | Short Float | 4.65% | Perf Quarter | 7.22% |
| Income | 0.26B | P/S | 7.36 | EPS this Y | 7.93% | Inst Trans | 3.64% | Short Ratio | 6.61 | Perf Half Y | 5.4% |
| Sales | 6.44B | P/B | 3.17 | EPS next 5Y | 32.85% | ROA | 0.94% | Short Interest | 23.70M | Perf YTD | 16.88% |
| Book/sh | 28.56 | P/C | 211.88 | EPS past 3/5Y | - -14.17% | ROE | 2.01% | 52W High | -10.98% ($101.60) | Perf Year | 30.6% |
| Cash/sh | 0.43 | P/FCF | 32.89 | Sales past 3/5Y | 12.23% 8.99% | ROIC | 0.98% | 52W Low | 35.92% ($66.54) | Perf 3Y | 116.68% |
| Dividend Est. | $2.08 (2.3%) | EV/EBITDA | 25.74 | EPS Y/Y TTM | 26.45% | Gross Margin | 18.38% | Volatility(W/M) | 1.98% 2% | Perf 5Y | 64.12% |
| Dividend TTM | 2 | EV/Sales | 9.43 | Sales Y/Y TTM | 21.49% | Oper. Margin | 14.83% | ATR (14) | 1.95 | Perf 10Y | 33.93% |
| Dividend Ex-Date | 2026/6/30 | Quick Ratio | 0.71 | EPS Q/Q | -4.64% | Profit Margin | 4.08% | RSI (14) | 44.65 | Recom | 1.54 |
| Dividend Gr. 3/5Y | 2.17% -2.15% | Current Ratio | 0.71 | Sales Q/Q | 21.73% | SMA20 | -1.41% ($91.73) | Beta | 0.74 | Target Price | $102.24 |
| Payout | 353.33% | Debt/Eq | 0.89 | Earnings | 2026/7/29 | SMA50 | -2.64% ($92.89) | Rel Volume | 0.77 | Prev Close | $89.38 |
| Employees | 542 | LT Debt/Eq | 0.84 | EPS/Sales Surpr. | -1.62% 2.91% | SMA200 | 6% ($85.32) | Avg Volume(3M) | 3.58M | Price | $90.44 |
| IPO | 1989/9/19 | Option/Short | Yes/Yes | Trades | 24589 | Volume | 2,760,470 | Change | 1.19% |
Company
VTR is a Real Estate sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 This is a major U.S. healthcare REIT that operates senior housing, medical office buildings, and life science research facilities. Since its spin-off launch in 1998, it has managed an extensive healthcare real estate portfolio across North America and the United Kingdom, with a focus on senior housing, and is widely regarded as a key beneficiary of population aging trends.
Over the past 1 year, roughly in the middle
11% below its 1-year high.
VTR has weak earning power
14.83% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.9% this year.
Tap to view numbers
The price looks about right
Trading at 165.9 times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +116.7% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.30% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 104.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 in the industry
Based on market cap of $47B.
FAQ
What kind of company is VTR?
VTR belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of VTR?
The market cap of VTR is approximately $47.4B, ranking 335 within its sector.
Does VTR pay dividends?
VTR has a dividend yield of approximately 2.30%, with an annual dividend of $2.08.
What is the P/E ratio of VTR?
VTR has a P/E ratio of approximately 165.9x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for VTR?
VTR has recorded a 52-week high of $101.60 and a low of $66.54.